Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 13 hours ago
BlossomHill eyes IPO as fertilizer to grow taller in crowded cancer fields
about 13 hours ago
Another biotech is squeezing into the crowded IPO waiting room just in...
Abbott Q2 led by strong device, diagnostic sales as it boosts profit forecast
about 14 hours ago
Abbott turned in a stronger than expected second quarter, allaying market concerns...
BIO San Diego 2026 Executive Interviews
about 15 hours ago
Every year, the BIO International Convention brings together more than 20,000 leaders...
Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Mirador
about 15 hours ago
Jasper Therapeutics is being reborn via a merger with Nasdaq-listed immune-mediated disease...
Chutes & Ladders—Cue lines up new CMO and research head
about 16 hours ago
Cue Biopharma is tapping in a new chief medical officer and head...
5 emerging biotech hubs
about 17 hours ago
Boston. San Francisco. Beijing? The global biotech industry has long been concentrated...
GSK axes key cough drug candidate after phase 3 data end blockbuster hopes
about 20 hours ago
GSK has ended development of camlipixant in chronic cough after delivering mixed...
Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal
about 21 hours ago
Dimerix has bought an acute kidney injury drug from Mission Therapeutics, paying...
Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 update
1 day ago
Takeda has unveiled more data from its phase 3 trials of zasocitinib...
Understanding Agentic AI in Clinical Development
1 day ago
Earlier this year, my colleague Matt Harrington suggested that clinical leaders should...
Nobel Laureate Jennifer Doudna enters AI protein design arena
1 day ago
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR...
Why Axiom hopes it’s ‘solved 2 major potholes’ that have hurt other stem cell biotechs
1 day ago
When Axiom's stem cell therapy demonstrated a 0% mortality rate over two...